Drug recall D-0374-2023
Product
Atorvastatin Calcium Tablets USP 80 mg* Rx Only, Packaged as a) 90 Tablets NDC 16729-047-15 UPC 3 16729 04715 9; b) 500 Tablets NDC 16729-047-16 UPC 3 16729 04716 6; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA
Reason for recall
CGMP Deviations: recalling drug products following an FDA inspection.
Lots and codes
Batches: a)R2100283, R2100288, R2100289, Exp. Date 2/28/2023; R2200235, Exp. Date 1/31/2024; R2201037, R2200952, Exp. Date 6/30/2024; b) R2100291, R2100281, R2100282, R2100292, R2100293, R2100294, R2100290, R2100306, R2100348, R2100349, R2100347, R2100350, R2100356, R2100355, Exp. Date 2/28/2023; R2100461, R2100463, R2100464, Exp. Date 3/31/2023; R2101214, R2101215, R2101216, Exp. Date 9/30/2023; R2101572, R2101573, R2101577, R2101578, R2101585, R2101579, R2101584, R2101587, R2101597, Exp. Date 11/30/2023; R2200801, Exp. Date 6/30/2024;
Recall details
- Recalling firm
- Accord Healthcare, Inc., Durham, NC
- Quantity
- 72,376 bottles
- Distribution
- United States including Puerto Rico and Canada
- Type
- Voluntary: Firm initiated
- Recall initiated
- February 7, 2023
- Terminated
- April 22, 2024
Related products
- Atorvastatin Calcium – drug information
- NDC 16729-044 Atorvastatin Calcium · Atorvastatin Calcium Trihydrate 10 mg/1 · Accord Healthcare Inc.
- NDC 16729-047 Atorvastatin Calcium · Atorvastatin Calcium Trihydrate 80 mg/1 · Accord Healthcare Inc.
- NDC 16729-046 Atorvastatin Calcium · Atorvastatin Calcium Trihydrate 40 mg/1 · Accord Healthcare Inc.
- NDC 16729-045 Atorvastatin Calcium · Atorvastatin Calcium Trihydrate 20 mg/1 · Accord Healthcare Inc.